Lipid-lowering therapies and cardiovascular risk-stratification strategies in adults with type 1 diabetes.
Current opinion in endocrinology, diabetes, and obesity（2023）
摘要
Clinical trial evidence for lipid-lowering therapies in T1D is lacking, and further studies are needed to inform best practice. Optimization and harmonization of ASCVD risk-stratification and lipid management in individuals with T1D is required.
更多查看译文
关键词
cardiovascular diseases,diabetes mellitus type 1,dyslipidaemias,risk factors,statins
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要